Sodium 18F-Fluoride Bone Scintigraphy in Deep Ocean Diver

被引:1
|
作者
Lim, Jin T. E. [1 ]
Moncayo, Valeria M. [1 ]
Alazraki, Naomi [1 ,2 ]
机构
[1] Emory Univ, Dept Radiol & Imaging Sci, Div Nucl Med & Mol Imaging, Atlanta, GA 30322 USA
[2] Vet Affairs Med Ctr, Nucl Med Serv, Atlanta, GA 30033 USA
关键词
METASTASES; INFARCT;
D O I
10.1097/RLU.0000000000000801
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Sodium F-18-fluoride (NaF) is a diagnostic marker for new bone formation in bone scintigraphy that was approved by US FDA in 1972 but discontinued in 1984. We report a case of a US naval officer who spent time living and working in an oceanic lab, 205 feet below the surface. Plain skeletal films of femurs 4 years later demonstrate bilateral bone infarcts. Corresponding sodium F-18-fluoride bone scintigraphy demonstrates low-normal to decreased tracer activity. This rectilinear scan image is of historical interest. Other bone scintigraphic radiotracers used in the past and present will be briefly discussed.
引用
收藏
页码:582 / 584
页数:3
相关论文
共 50 条
  • [1] 18F-Fluoride PET/CT in patients with equivocal bone scintigraphy
    Bortot, D. C.
    Oki, G. C. R.
    Amorim, B. J.
    Gapski, S. B.
    Ruiz, P. P. G.
    Arouca, P. T.
    Santos, A. O.
    Lima, M. C. L.
    Etchebehere, E. C. S. C.
    Camargo, E. E.
    Barbosa, M. F.
    Menguatti, J.
    Ramos, C. D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S353 - S353
  • [2] Comparison of 18F-fluoride PET/CT and conventional bone scintigraphy in patients with spondyloarthropathies
    Strobel, K.
    Stumpe, K. D.
    Hany, T. F.
    Soyka, J. D.
    Veit-Haibach, P.
    Tamborrini, G.
    Kyburz, D.
    von Schulthess, G. K.
    Ciurea, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S137 - S137
  • [3] Sodium 18F-Fluoride PET/CT of Bone, Joint, and Other Disorders
    Jadvar, Hossein
    Desai, Bhushan
    Conti, Peter S.
    SEMINARS IN NUCLEAR MEDICINE, 2015, 45 (01) : 58 - 65
  • [4] 18F-fluoride as a prognostic indicator of bone regeneration
    Mathavan, Neashan
    Koopman, Janine
    Raina, Deepak Bushan
    Turkiewicz, Aleksandra
    Tagil, Magnus
    Isaksson, Hanna
    ACTA BIOMATERIALIA, 2019, 90 : 403 - 411
  • [5] Clinical usefulness of 18F-fluoride bone PET
    Kang J.Y.
    Lee W.W.
    So Y.
    Lee B.C.
    Kim S.E.
    Nuclear Medicine and Molecular Imaging, 2010, 44 (1) : 55 - 61
  • [6] Bone metastasis: comparison between 18F-fluoride PET/CT and 99mTc-MDP bone scintigraphy
    Antunovic, L.
    Ciocia, G.
    Chiti, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S133 - S134
  • [7] 18F-Fluoride PET/CT is highly effective for excluding bone metastases even in patients with equivocal bone scintigraphy
    Bortot, Daniel C.
    Amorim, Barbara J.
    Oki, Glaucia C.
    Gapski, Sergio B.
    Santos, Allan O.
    Lima, Mariana C. L.
    Etchebehere, Elba C. S. C.
    Barboza, Marycel F.
    Mengatti, Jair
    Ramos, Celso Dario
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (11) : 1730 - 1736
  • [8] 18F-Fluoride PET/CT is highly effective for excluding bone metastases even in patients with equivocal bone scintigraphy
    Daniel C. Bortot
    Bárbara J. Amorim
    Glaucia C. Oki
    Sérgio B. Gapski
    Allan O. Santos
    Mariana C. L. Lima
    Elba C. S. C. Etchebehere
    Marycel F. Barboza
    Jair Mengatti
    Celso Dario Ramos
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 1730 - 1736
  • [9] SNM Practice Guideline for Sodium 18F-Fluoride PET/CT Bone Scans 1.0
    Segall, George
    Delbeke, Dominique
    Stabin, Michael G.
    Even-Sapir, Einat
    Fair, Joanna
    Sajdak, Rebecca
    Smith, Gary T.
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (11) : 1813 - 1820
  • [10] 18F-Fluoride PET in the Assessment of Malignant Bone Disease
    Iagaru, Andrei
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (10) : 1476 - 1477